Generics & Biosimilars | Association for Accessible Medicines
ICYMI - View memorable moments and quotes from #Access2021
  • SecureOurMeds
    Congress Can Help to Secure Our Meds
    Generic and biosimilar medicines are essential to treating millions of patients. Together, we can take steps to secure patient access no matter what challenges may arise.
  • Dan Leonard, AAM CEO and President, by his desk
    While We Await Vaccine Progress, We Can Trust in Generic Drugs
    Read AAM CEO Dan Leonard's article on the essential role generic drugs play during the COVID-19, while we await a vaccine.
  • Interactive Savings Map 2020
    Health Care Savings, State by State
    The average state saved $6.1 billion from the use of generic drugs in 2019. How much did your state save?
  • ""
    Industry Response to COVID-19
    The coronavirus (COVID-19) pandemic is disrupting everyday life around the world and imposing unprecedented stress on our health care system. Here are some responses and resources from the U.S. generics and biosimilars industry.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.